loader
Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for Apalutamide Active Pharmaceutical Ingredient (API)

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Apalutamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,232Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    22/09/2022 Dr. Reddy\\\'s Laboratories
    India
    		 M/s Dr. Reddy's Laboratories Ltd WC-0390 Apalutamide IH 2022-07-28 2025-11-30 CTO-SEZ-Process Unit-01, Sector No 28 to 34, 36 to 37, 40, 50 to 53 & 03, Survey No, 57 to 58, 60, 72 to 73, 76 to 77 & 80, Devunipalavalasa Village, Ranasthalam Mandal, Srikakulam District- 532409, Andhra Pradesh, India
    07/08/2024 Alembic Pharmaceuticals Limited
    India
    		 M/s. Alembic Pharmaceuticals Limited WC-0082 Apalutamide IHS 2022-06-17 2025-07-02 API Division Kharakhadi, Plot No. 842-843, Kharakhadi, Padra Vadodara-391 450, Gujarat India